Yoshitaka Narita

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 30

Top Venues

Cancers

Japanese journal of clinical oncology

Neuro-oncology advances

Neuro-oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Yuki Kawaguchi, Yuko Watanabe, Yasuji Miyakita, Makoto Ohno, Chitose Ogawa, Masamichi Takahashi, Shunsuke Yanagisawa, Takayuki Mukai, Hiroshi Igaki, Hirokazu Sugino, Akihiko Yoshida, Yoshitaka Narita
Successful treatment of pediatric patients with high-grade gliomas featuring leptomeningeal metastases by targeting BRAF V600E mutations with dabrafenib plus trametinib: two illustrative cases. International cancer conference journal 13 (3) (2024)
Yuki Kawaguchi, Yuko Watanabe, Yasuji Miyakita, Makoto Ohno, Chitose Ogawa, Masamichi Takahashi, Shunsuke Yanagisawa, Takayuki Mukai, Hiroshi Igaki, Hirokazu Sugino, Akihiko Yoshida, Yoshitaka Narita
Successful treatment of pediatric patients with high-grade gliomas featuring leptomeningeal metastases by targeting BRAF V600E mutations with dabrafenib plus trametinib: two illustrative cases. International cancer conference journal 13 (3) (2024)
Takahiro Tsuchiya, Daisuke Kawauchi, Makoto Ohno, Yasuji Miyakita, Masamichi Takahashi, Shunsuke Yanagisawa, Sho Osawa, Shohei Fujita, Takaki Omura, Yoshitaka Narita
Risk Factors of Distant Recurrence and Dissemination of IDH Wild-Type Glioblastoma: A Single-Center Study and Meta-Analysis. Cancers 16 (16) (2024)
Sho Osawa, Yasuji Miyakita, Masamichi Takahashi, Makoto Ohno, Shunsuke Yanagisawa, Daisuke Kawauchi, Takaki Omura, Shohei Fujita, Takahiro Tsuchiya, Junya Matsumi, Tetsufumi Sato, Yoshitaka Narita
The Safety and Usefulness of Awake Surgery as a Treatment Modality for Glioblastoma: A Retrospective Cohort Study and Literature Review. Cancers 16 (15) (2024)
Kazuya Motomura, Keita Sasaki, Narushi Sugii, Shigeru Yamaguchi, Hirotaka Inoue, Akito Oshima, Kazuhiro Tanaka, Yoshihiro Otani, Mitsuaki Shirahata, Ichiyo Shibahara, Motoo Nagane, Shunsuke Tsuzuki, Tomoo Matsutani, Yoshihiro Tsukamoto, Noriyuki Kijima, Kenichiro Asano, Makoto Ohno, Akihiro Inoue, Yohei Mineharu, Keisuke Miyake, Yuta Mitobe, Mitsuto Hanihara, Yu Kawanishi, Shoichi Deguchi, Masato Saito, Ryosuke Matsuda, Kenta Ujifuku, Hideyuki Arita, Yuichi Sato, Shinji Yamashita, Ushio Yonezawa, Junya Yamaguchi, Yasutomo Momii, Takahiro Ogawa, Atsushi Kambe, Shigeo Ohba, Junya Fukai, Norihiko Saito, Masashi Kinoshita, Koichiro Sumi, Ryohei Otani, Takeo Uzuka, Noriyoshi Takebe, Shinichiro Koizumi, Ryuta Saito, Yoshiki Arakawa, Yoshitaka Narita, null null
Cost of medical care for malignant brain tumors at hospitals in the Japan Clinical Oncology Group brain-tumor study group. Japanese journal of clinical oncology (2024)
Hajime Yonezawa, Yoshitaka Narita, Motoo Nagane, Kazuhiko Mishima, Yasuhito Terui, Yoshiki Arakawa, Katsunori Asai, Noriko Fukuhara, Kazuhiko Sugiyama, Naoki Shinojima, Arata Aoi, Ryo Nishikawa
Three-year follow-up analysis of phase 1/2 study on tirabrutinib in patients with relapsed or refractory primary central nervous system lymphoma. Neuro-oncology advances 6 (1) (2024)
Sho Osawa, Yasuji Miyakita, Masamichi Takahashi, Makoto Ohno, Shunsuke Yanagisawa, Daisuke Kawauchi, Takaki Omura, Shohei Fujita, Takahiro Tsuchiya, Junya Matsumi, Tetsufumi Sato, Yoshitaka Narita
The Safety and Usefulness of Awake Surgery as a Treatment Modality for Glioblastoma: A Retrospective Cohort Study and Literature Review. Cancers 16 (15) (2024)
Hajime Yonezawa, Yoshitaka Narita, Motoo Nagane, Kazuhiko Mishima, Yasuhito Terui, Yoshiki Arakawa, Katsunori Asai, Noriko Fukuhara, Kazuhiko Sugiyama, Naoki Shinojima, Arata Aoi, Ryo Nishikawa
Three-year follow-up analysis of phase 1/2 study on tirabrutinib in patients with relapsed or refractory primary central nervous system lymphoma. Neuro-oncology advances 6 (1) (2024)
Takahiro Tsuchiya, Daisuke Kawauchi, Makoto Ohno, Yasuji Miyakita, Masamichi Takahashi, Shunsuke Yanagisawa, Sho Osawa, Shohei Fujita, Takaki Omura, Yoshitaka Narita
Risk Factors of Distant Recurrence and Dissemination of IDH Wild-Type Glioblastoma: A Single-Center Study and Meta-Analysis. Cancers 16 (16) (2024)
Ryo Nishikawa, Fumiyuki Yamasaki, Yoshiki Arakawa, Yoshihiro Muragaki, Yoshitaka Narita, Shota Tanaka, Shigeru Yamaguchi, Akitake Mukasa, Masayuki Kanamori
Safety and efficacy of tumour-treating fields (TTFields) therapy for newly diagnosed glioblastoma in Japanese patients using the Novo-TTF System: a prospective post-approval study. Japanese journal of clinical oncology (2023)
Ryo Nishikawa, Fumiyuki Yamasaki, Yoshiki Arakawa, Yoshihiro Muragaki, Yoshitaka Narita, Shota Tanaka, Shigeru Yamaguchi, Akitake Mukasa, Masayuki Kanamori
Safety and efficacy of tumour-treating fields (TTFields) therapy for newly diagnosed glioblastoma in Japanese patients using the Novo-TTF System: a prospective post-approval study. Japanese journal of clinical oncology (2023)
Yoshiki Arakawa, Yoshitaka Narita, Motoo Nagane, Kazuhiko Mishima, Yasuhito Terui, Hajime Yonezawa, Katsunori Asai, Noriko Fukuhara, Kazuhiko Sugiyama, Naoki Shinojima, Arata Aoi, Ryo Nishikawa
Karnofsky Performance Status and quality of life in patients with relapsed or refractory primary CNS lymphoma from a phase I/II study of tirabrutinib. Neuro-oncology advances 5 (1) (2023)
Daisuke Kawauchi, Makoto Ohno, Yasuji Miyakita, Masamichi Takahashi, Shunsuke Yanagisawa, Takaki Omura, Akihiko Yoshida, Yuko Kubo, Hiroshi Igaki, Koichi Ichimura, Yoshitaka Narita
Consulting a neurosurgeon upon initial medical assessment reduces the time to the first surgery and potentially contributes to improved prognosis for glioblastoma patients. Japanese journal of clinical oncology (2023)
Tomohiro Hosoya, Masamichi Takahashi, Mai Honda-Kitahara, Yasuji Miyakita, Makoto Ohno, Shunsuke Yanagisawa, Takaki Omura, Daisuke Kawauchi, Yukie Tamura, Miyu Kikuchi, Tomoyuki Nakano, Akihiko Yoshida, Hiroshi Igaki, Yuko Matsushita, Koichi Ichimura, Yoshitaka Narita
MGMT gene promoter methylation by pyrosequencing method correlates volumetric response and neurological status in IDH wild-type glioblastomas. Journal of neuro-oncology 157 (3) (2022)
Takaki Omura, Masamichi Takahashi, Makoto Ohno, Yasuji Miyakita, Shunsuke Yanagisawa, Yukie Tamura, Miyu Kikuchi, Daisuke Kawauchi, Tomoyuki Nakano, Tomohiro Hosoya, Hiroshi Igaki, Kaishi Satomi, Akihiko Yoshida, Kuniko Sunami, Makoto Hirata, Tatsunori Shimoi, Kazuki Sudo, Hitomi S Okuma, Kan Yonemori, Hiromichi Suzuki, Koichi Ichimura, Yoshitaka Narita
Clinical Application of Comprehensive Genomic Profiling Tests for Diffuse Gliomas. Cancers 14 (10) (2022)
Atsushi Natsume, Yoshiki Arakawa, Yoshitaka Narita, Kazuhiko Sugiyama, Nobuhiro Hata, Yoshihiro Muragaki, Naoki Shinojima, Toshihiro Kumabe, Ryuta Saito, Kazuya Motomura, Yohei Mineharu, Yasuji Miyakita, Fumiyuki Yamasaki, Yuko Matsushita, Koichi Ichimura, Kazumi Ito, Masaya Tachibana, Yasuyuki Kakurai, Naoko Okamoto, Takashi Asahi, Soichiro Nishijima, Tomoyuki Yamaguchi, Hiroshi Tsubouchi, Hideo Nakamura, Ryo Nishikawa
The first-in-human phase I study of a brain penetrant mutant IDH1 inhibitor DS-1001 in patients with recurrent or progressive IDH1-mutant gliomas. Neuro-oncology (2022)
Kazuhiko Mishima, Ryo Nishikawa, Yoshitaka Narita, Junki Mizusawa, Minako Sumi, Tomoyuki Koga, Nobuyoshi Sasaki, Manabu Kinoshita, Motoo Nagane, Yoshiki Arakawa, Koji Yoshimoto, Ichiyo Shibahara, Naoki Shinojima, Kenichiro Asano, Takao Tsurubuchi, Hikaru Sasaki, Akio Asai, Takashi Sasayama, Yasutomo Momii, Atsushi Sasaki, Shigeo Nakamura, Masaru Kojima, Junichi Tamaru, Kazuhiro Tsuchiya, Miho Gomyo, Kayoko Abe, Manabu Natsumeda, Fumiyuki Yamasaki, Hiroshi Katayama, Haruhiko Fukuda
Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C. Neuro-oncology (2022)
Hirokazu Takami, Asmaa Elzawahry, Yasin Mamatjan, Shintaro Fukushima, Kohei Fukuoka, Tomonari Suzuki, Takaaki Yanagisawa, Yuko Matsushita, Taishi Nakamura, Kaishi Satomi, Shota Tanaka, Akitake Mukasa, Nobuhito Saito, Masayuki Kanamori, Toshihiro Kumabe, Teiji Tominaga, Keiichi Kobayashi, Motoo Nagane, Toshihiko Iuchi, Kaoru Tamura, Taketoshi Maehara, Kazuhiko Sugiyama, Koji Yoshimoto, Keiichi Sakai, Masahiro Nonaka, Akio Asai, Kiyotaka Yokogami, Hideo Takeshima, Yoshitaka Narita, Soichiro Shibui, Yoichi Nakazato, Natsuko Hama, Yasushi Totoki, Mamoru Kato, Tatsuhiro Shibata, Ryo Nishikawa, Masao Matsutani, Koichi Ichimura
Transcriptome and methylome analysis of CNS germ cell tumor finds its cell-of-origin in embryogenesis and reveals shared similarities with testicular counterparts. Neuro-oncology 24 (8) (2022)
Makoto Ohno, Chifumi Kitanaka, Yasuji Miyakita, Shota Tanaka, Yukihiko Sonoda, Kazuhiko Mishima, Eiichi Ishikawa, Masamichi Takahashi, Shunsuke Yanagisawa, Ken Ohashi, Motoo Nagane, Yoshitaka Narita
Metformin with Temozolomide for Newly Diagnosed Glioblastoma: Results of Phase I Study and a Brief Review of Relevant Studies. Cancers 14 (17) (2022)
Tomohiro Hosoya, Masamichi Takahashi, Calvin Davey, Jun Sese, Mai Honda-Kitahara, Yasuji Miyakita, Makoto Ohno, Shunsuke Yanagisawa, Takaki Omura, Daisuke Kawauchi, Yukie Ozeki, Miyu Kikuchi, Tomoyuki Nakano, Akihiko Yoshida, Hiroshi Igaki, Yuko Matsushita, Koichi Ichimura, Yoshitaka Narita
Volumetric Analysis of Glioblastoma for Determining Which CpG Sites Should Be Tested by Pyrosequencing to Predict Temozolomide Efficacy. Biomolecules 12 (10) (2022)
Yoshitaka Narita, Yoshiko Okita, Yoshiki Arakawa
Evaluation of the efficacy and safety of TAS0313 in adults with recurrent glioblastoma. Cancer immunology, immunotherapy : CII 71 (11) (2022)
Daisuke Kawauchi, Makoto Ohno, Mai Honda-Kitahara, Yasuji Miyakita, Masamichi Takahashi, Shunsuke Yanagisawa, Yukie Tamura, Miyu Kikuchi, Koichi Ichimura, Yoshitaka Narita
The clinical characteristics and outcomes of incidentally discovered glioblastoma. Journal of neuro-oncology 156 (3) (2022)
Quirien Oort, Linda Dirven, Sietske A M Sikkes, Neil Aaronson, Florien W Boele, Christine Brannan, Jonas Egeter, Robin Grant, Martin Klein, Irene M Lips, Yoshitaka Narita, Hitomi Sato, Monika Sztankay, Günther Stockhammer, Andrea Talacchi, Bernard M J Uitdehaag, Jaap C Reijneveld, Martin J B Taphoorn
Do neurocognitive impairments explain the differences between brain tumor patients and their proxies when assessing the patient's IADL? Neuro-oncology practice 9 (4) (2022)
Makoto Ohno, Yasuji Miyakita, Masamichi Takahashi, Shunsuke Yanagisawa, Yukie Tamura, Yoshitaka Narita
Continuing maintenance temozolomide therapy beyond 12 cycles confers no clinical benefit over discontinuation at 12 cycles in patients with IDH1/2-wildtype glioblastoma. Japanese journal of clinical oncology 52 (10) (2022)
Motoo Nagane, Koichi Ichimura, Ritsuko Onuki, Daichi Narushima, Mai Honda-Kitahara, Kaishi Satomi, Arata Tomiyama, Yasuhito Arai, Tatsuhiro Shibata, Yoshitaka Narita, Takeo Uzuka, Hideo Nakamura, Mitsutoshi Nakada, Yoshiki Arakawa, Takanori Ohnishi, Akitake Mukasa, Shota Tanaka, Toshihiko Wakabayashi, Tomokazu Aoki, Shigeki Aoki, Soichiro Shibui, Masao Matsutani, Keisuke Ishizawa, Hideaki Yokoo, Hiroyoshi Suzuki, Satoshi Morita, Mamoru Kato, Ryo Nishikawa
Bevacizumab beyond Progression for Newly Diagnosed Glioblastoma (BIOMARK): Phase II Safety, Efficacy and Biomarker Study. Cancers 14 (22) (2022)
Masayuki Kanamori, Hirokazu Takami, Tomonari Suzuki, Teiji Tominaga, Jun Kurihara, Shota Tanaka, Seiji Hatazaki, Motoo Nagane, Masahide Matsuda, Atsuo Yoshino, Manabu Natsumeda, Masayoshi Yamaoka, Naoki Kagawa, Yukinori Akiyama, Junya Fukai, Tetsuya Negoto, Ichiyo Shibahara, Kazuhiro Tanaka, Akihiro Inoue, Mitsuhiro Mase, Takahiro Tomita, Daisuke Kuga, Noriyuki Kijima, Tadateru Fukami, Yukiko Nakahara, Atsushi Natsume, Koji Yoshimoto, Dai Keino, Tsutomu Tokuyama, Kenichiro Asano, Kenta Ujifuku, Hiroshi Abe, Mitsutoshi Nakada, Ken-Ichiro Matsuda, Yoshiki Arakawa, Naokado Ikeda, Yoshitaka Narita, Naoki Shinojima, Atsushi Kambe, Masahiko Nonaka, Shuichi Izumoto, Yu Kawanishi, Kohei Kanaya, Sadahiro Nomura, Kohei Nakajima, Shohei Yamamoto, Keita Terashima, Koichi Ichimura, Ryo Nishikawa
Necessity for craniospinal irradiation of germinoma with positive cytology without spinal lesion on MR imaging-A controversy. Neuro-oncology advances 3 (1) (2021)
Yoshitaka Narita, Shinya Sato, Takamasa Kayama
Review of the diagnosis and treatment of brain metastases. Japanese journal of clinical oncology (2021)
Hirokazu Takami, Kaishi Satomi, Kohei Fukuoka, Shintaro Fukushima, Yuko Matsushita, Kai Yamasaki, Taishi Nakamura, Shota Tanaka, Akitake Mukasa, Nobuhito Saito, Tomonari Suzuki, Takaaki Yanagisawa, Hideo Nakamura, Kazuhiko Sugiyama, Kaoru Tamura, Taketoshi Maehara, Mitsutoshi Nakada, Masahiro Nonaka, Akio Asai, Kiyotaka Yokogami, Hideo Takeshima, Toshihiko Iuchi, Yonehiro Kanemura, Keiichi Kobayashi, Motoo Nagane, Kazuhiko Kurozumi, Koji Yoshimoto, Masahide Matsuda, Akira Matsumura, Yuichi Hirose, Tsutomu Tokuyama, Toshihiro Kumabe, Yoshitaka Narita, Soichiro Shibui, Yoichi Nakazato, Ryo Nishikawa, Masao Matsutani, Koichi Ichimura
Low tumor cell content predicts favorable prognosis in germinoma patients. Neuro-oncology advances 3 (1) (2021)
Yoshitaka Narita, Yoshihiro Muragaki, Naoki Kagawa, Katsunori Asai, Motoo Nagane, Masahide Matsuda, Keisuke Ueki, Junichiro Kuroda, Isao Date, Hiroyuki Kobayashi, Toshihiro Kumabe, Takaaki Beppu, Masayuki Kanamori, Shota Kasai, Yasuko Nishimura, Hao Xiong, Christopher Ocampo, Masakazu Yamada, Kazuhiko Mishima
Safety and efficacy of depatuxizumab mafodotin in Japanese patients with malignant glioma: A nonrandomized, phase 1/2 trial. Cancer science 112 (12) (2021)
Shinji Kawabata, Minoru Suzuki, Katsumi Hirose, Hiroki Tanaka, Takahiro Kato, Hiromi Goto, Yoshitaka Narita, Shin-Ichi Miyatake
Accelerator-based BNCT for patients with recurrent glioblastoma: a multicenter phase II study. Neuro-oncology advances 3 (1) (2021)

Yoshitaka Narita.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yoshitaka Narita